4//SEC Filing
Shailubhai Kunwar 4
Accession 0001104659-11-068400
CIK 0001347613other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:27 PM ET
Size
6.2 KB
Accession
0001104659-11-068400
Insider Transaction Report
Form 4
Shailubhai Kunwar
Chief Scientific Officer
Transactions
- Purchase
Units
2011-12-06$8.00/sh+12,788$102,304→ 12,788 total→ Common Stock and Warrants (38,364 underlying)
Footnotes (3)
- [F1]Dr. Shailubhai purchased 12,788 units of the issuer in a public offering at a purchase price of $8.00 per unit. Each unit consists of two shares of common stock and one common stock purchase warrant.
- [F2]The common stock and warrants included in the units will not be separately transferable until the earlier of (i) the exercise in full of the underwriters' overallotment option or (ii) January 15, 2012. Each warrant will have an exercise price of $5.50 per share, will be exercisable upon separation of the units and will expire five years from the date of issuance.
- [F3]Consists of 25,576 shares of common stock and 12,788 shares of common stock issuable upon exercise of warrants.
Documents
Issuer
SYNERGY PHARMACEUTICALS, INC.
CIK 0001347613
Entity typeother
Related Parties
1- filerCIK 0001307746
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:27 PM ET
- Size
- 6.2 KB